Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-NK”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Enrolling By InvitationNCT06518668
What this trial is testing

NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Hospital for Special Surgery, New York 6
Not applicableNot Yet RecruitingNCT06594211
What this trial is testing

Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma

Who this might be right for
Multiple Myeloma
RenJi Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT07622940
What this trial is testing

Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma

Who this might be right for
Recurrent or Metastatic Esophageal AdenocarcinomaBiomarker-selected CLDN18.2-positive and/or HER2-positive Disease
Beijing Biotech 36
Early research (Phase 1)UnknownNCT05410041
What this trial is testing

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
Beijing Boren Hospital 15
Testing effectiveness (Phase 2)UnknownNCT05941156
What this trial is testing

Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia

Who this might be right for
Extranodal NK T Cell LymphomaNK-Cell Leukemia
The Affiliated Hospital of Xuzhou Medical University 20
Very early researchLooking for participantsNCT06469190
What this trial is testing

An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy

Who this might be right for
Nephropathy
Changhai Hospital 36
Very early researchUnknownNCT05574608
What this trial is testing

Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia Recurrent
Affiliated Hospital to Academy of Military Medical Sciences 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07504289
What this trial is testing

CAR-NK Therapy for Cardiac Amyloidosis

Who this might be right for
Light Chain Cardiac Amyloidosis
Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Testing effectiveness (Phase 2)Looking for participantsNCT07617753
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma+1 more
Beijing Biotech 36
Early research (Phase 1)UnknownNCT04008394
What this trial is testing

Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies

Who this might be right for
Adult T-Cell Lymphoma/LeukaemiaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Very early researchLooking for participantsNCT06643221
What this trial is testing

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

Who this might be right for
LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more
University of Arizona 200
Not applicableUnknownNCT06727383
What this trial is testing

CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors

Who this might be right for
Healthy DonorsMyeloproliferative DiseasesLymphoproliferative Disorders
European Institute of Oncology 140
Very early researchNot Yet RecruitingNCT07243366
What this trial is testing

Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis

Who this might be right for
Refractory Myasthenia Gravis
Guangdong ProCapZoom Biosciences Co., Ltd. 15
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07137481
What this trial is testing

Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Looking for participantsNCT07744256
What this trial is testing

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCExtensive-stage SCLC
Beijing Biotech 60
Testing effectiveness (Phase 2)Looking for participantsNCT05110742
What this trial is testing

Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

Who this might be right for
Hematological Malignancy
M.D. Anderson Cancer Center 64
Very early researchUnknownNCT05652530
What this trial is testing

Clinical Study of the Safety and Efficacy of BCMA CAR-NK

Who this might be right for
ImmunotherapyMultiple Myeloma
Shenzhen Pregene Biopharma Co., Ltd. 19
Testing effectiveness (Phase 2)Looking for participantsNCT07411599
What this trial is testing

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

Who this might be right for
Colorectal CancerPeritoneal MetastasesCarcinomatosis
M.D. Anderson Cancer Center 28
Early research (Phase 1)UnknownNCT04004637
What this trial is testing

CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia

Who this might be right for
T-lymphoblastic LymphomaNK/T Cell LymphomaAcute Lymphocytic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Next Page